Correction to: Cancer Cell Int (2018) 18:215 https://doi.org/10.1186/s12935-018-0716-7
Reference
Cao X-x, Cai H, Mao Y-y, Wu Q. Zhang Lu, Zhou D-b, Jian L. Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients. Cancer Cell Int. 2018;18:215. https://doi.org/10.1186/s12935-018-0716-7.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Cao, Xx., Cai, H., Mao, Yy. et al. Correction to: Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients. Cancer Cell Int 19, 14 (2019). https://doi.org/10.1186/s12935-019-0736-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12935-019-0736-y